Trials / Completed
CompletedNCT04239950
Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 316 (actual)
- Sponsor
- Mochida Pharmaceutical Company, Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of ethyl icosapentate in Chinese patients with severe hypertriglyceridemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Placebo |
| DRUG | Ethyl Icosapentate | Ethyl Icosapentate |
Timeline
- Start date
- 2020-05-09
- Primary completion
- 2023-07-20
- Completion
- 2023-07-20
- First posted
- 2020-01-27
- Last updated
- 2024-07-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04239950. Inclusion in this directory is not an endorsement.